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It was a pleasure to read the elegant and witty commentary
by Gutierrez and Fuller [1] regarding our paper published in
Shock [2] on resuscitation of rats using our aloe-derived
drag-reducing polymer (DRP) solution. However, we disagree
with the statement that, ‘the application of physical principles
to complex living organisms often requires assumptions ad
absurdum.’ There is always physics behind every natural
process, including physiological processes in living
organisms and hemodynamics. This is a well established and
widely recognized philosophical and methodological
principle. The physical explanation of systems characterized
by extreme complexity is a very difficult task that requires
many levels of approximation.
Concerning the effects of DRPs on blood circulation in
general, and the hypoperfusion associated with hemorrhagic
shock in particular, several synthetic (polyethylene oxides,
polyacrylamides) and natural (polysaccharides, DNA) DRPs
with completely different chemical structures were found to
produce exactly the same hemodynamic effects when
injected in blood at minute concentrations. The similarity in
effects observed with chemically distinct classes of
compounds with DRP-like activity supports the notion that
the beneficial effects are due to shared physical properties of
these agents.
We hope that readers of this journal will find time to examine
another report on the treatment of hemorrhagic shock in rats
using two high molecular weight polymers, which was
published in February 2004 in Biorheology [3]. The polymers
were synthetic polyethylene oxide (or polyethylene glycol
[PEG]) with a molecular mass of 3500 kDa (PEG-3500) and
the aloe-based DRP with a molecular mass of about
4000 kDa. In addition, we used PEG with a much lower
molecular mass of 200 kDa (PEG-200) in these experiments.
PEG-3500 and the aloe vera derived agent are DRPs. PEG-
200 possesses the same chemistry and structure of the
higher molecular weight PEG, but it has no drag-reducing
ability (the drag-reducing property was found in linear
polymers with molecular masses >1000 kDa). The major
findings were that the nanomolar concentrations of both
DRPs added to the resuscitation fluid prevented death in rats
from severe hemorrhage. However, PEG-200 did not
produce any beneficial effects when it was added to the
resuscitation fluid at 15 times the concentration. Thus, drag-
reducing or related viscoelastic properties of the applied
polymers were the most important factors in the improved
survival from severe hemorrhage. Incidentally, we did not
‘attribute systemic hemodynamic changes to decreases in
vascular frictional forces’ in our analysis of the obtained
results. On the contrary, we suggested that the major
beneficial effect of the polymers in hemorrhagic shock was
their effect on the red blood cell concentration in the
microvessel near-wall space (an increase in a microvessel
hematocrit) and attenuation of the plasma-skimming effect,
which, in fact, would increase the local viscosity and
microvessel wall shear stresses, potentially causing a release
of shear-dependent vasodilators selectively in microvessels.
Although the exact mechanisms of the intravascular effects of
DRPs are yet to be discovered, this extraordinary physical
phenomenon has great biomedical potential and warrants
further investigation.
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Authors’ response
Guillermo Gutierrez and Stephanie Fuller
We read with great interest the letter written by Kameneva
and Fink in response to our recent commentary [1] on the
circulatory effects of DRPs. We directed our comments to
the possibility that the salutary effects of aloe-derived DRPs
may have resulted from the well known antioxidant properties
of aloe vera. As pointed out by Kameneva and Fink in their
letter, posthemorrhage rats also exhibit improved survival
when infused with a DRP not derived from aloe vera [3]. This
finding supports their hypothesis that the beneficial effects of
DRP are related to alterations in blood rheology and not just
to the scavenging of oxygen free radical species.
A great deal of ground remains to be covered as we begin to
understand the in vivo rheological properties of DRPs. It may
be that the ‘spherical cows’ alluded to in our commentary
may be slimmer than originally thought!
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